Literature DB >> 22936124

Predominant prevalence of arterial thrombosis in Japanese patients with antiphospholipid syndrome.

Y Fujieda1, T Atsumi, O Amengual, T Odani, K Otomo, M Kato, K Oku, Y Kon, T Horita, S Yasuda, T Koike.   

Abstract

OBJECTIVE: To study the clinical and immunological manifestations of antiphospholipid syndrome (APS) in the Japanese population by a single-centre registration.
METHODS: In this retrospective cohort study, 141 consecutive patients with APS, fulfilling the Sydney revised Sapporo criteria for definite APS, who visited our autoimmune clinic from 1988 to 2010, were recruited and followed up. All the patients were interviewed and underwent a general physical examination by qualified rheumatologists on the day of blood sampling.
RESULTS: The population comprised 119 woman and 22 men with a mean age at diagnosis of 44 years (range 9-79 years). Seventy patients (49.6%) had primary APS, and 71 (50.4%) had systemic lupus erythematosus. The prevalence of thrombosis was 85.8 per cent, arterial thrombosis was found in 93 patients (66.0%) and venous thrombosis was found in 46 patients (32.6%). The most common thrombosis was cerebral infarction [86/141 (61.0%)] followed by deep vein thrombosis [33/141 (23.4%)]. Among 70 pregnant women, 45 (64.3%) had obstetric complications. Lupus anticoagulant was detected in 116 patients (82.3%), anticardiolipin antibodies in 83 (58.9%), anti-β2 glycoprotein I antibodies in 73 (51.8%) and phosphatidylserine-dependent antiprothrombin antibodies in 98 (69.5%).
CONCLUSION: High prevalence of arterial thrombosis was noted in Japanese patients with APS. The profile of heterogeneous and complex clinical manifestations was substantiated in Japanese patients with APS.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22936124     DOI: 10.1177/0961203312458469

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  9 in total

Review 1.  New insights into the pathogenic mechanisms and treatment of arterial thrombosis in antiphospholipid syndrome.

Authors:  Yuichiro Fujieda; Olga Amengual
Journal:  Eur J Rheumatol       Date:  2020-11-19

2.  Clinical characteristics and laboratory findings of 252 Chinese patients with anti-phospholipid syndrome: comparison with Euro-Phospholipid cohort.

Authors:  Hui Shi; Jia-Lin Teng; Yue Sun; Xin-Yao Wu; Qiong-Yi Hu; Hong-Lei Liu; Xiao-Bing Cheng; Yu-Feng Yin; Jun-Na Ye; Pojen P Chen; Cheng-de Yang
Journal:  Clin Rheumatol       Date:  2017-01-27       Impact factor: 2.980

3.  Presence of antiphospholipid antibody is a risk factor in thrombotic events in patients with antiphospholipid syndrome or relevant diseases.

Authors:  Koji Habe; Hideo Wada; Takeshi Matsumoto; Kohshi Ohishi; Makoto Ikejiri; Kimiko Matsubara; Tatsuhiko Morioka; Yuki Kamimoto; Tomoaki Ikeda; Naoyuki Katayama; Tsutomu Nobori; Hitoshi Mizutani
Journal:  Int J Hematol       Date:  2013-02-03       Impact factor: 2.490

4.  Antiphospholipid syndrome in Sarawak: real world experience in a developing country.

Authors:  C L Teh; T S Leong
Journal:  Clin Rheumatol       Date:  2014-05-16       Impact factor: 2.980

5.  Anaesthetic considerations for patients with antiphospholipid syndrome undergoing non-cardiac surgery.

Authors:  Jae Won Kim; Tae Woo Kim; Keon Hee Ryu; Sun Gyoo Park; Chang Young Jeong; Dong Ho Park
Journal:  J Int Med Res       Date:  2020-01       Impact factor: 1.671

6.  Evaluation of Frequency, Clinical Correlation, and Antibodies Confirmation Profile in Patients with Suspected Antiphospholipid Syndrome.

Authors:  Filipe F Martins; Teresa M L Campos
Journal:  TH Open       Date:  2021-10-19

Review 7.  Clinical Management of Thrombotic Antiphospholipid Syndrome.

Authors:  Nor Rafeah Tumian; Beverley J Hunt
Journal:  J Clin Med       Date:  2022-01-29       Impact factor: 4.241

8.  A Lotus Root-like Appearance in the External Iliac Artery Detected by Intravascular Ultrasonography.

Authors:  Makoto Takeuchi; Takenori Okada; Takahiro Ohmine; Yuki Ikegami; Yumiko Nakamoto; Naomi Idei; Norihiko Ohashi
Journal:  Intern Med       Date:  2021-08-24       Impact factor: 1.271

9.  A retrospective review of antiphospholipid syndrome from a South Asian country.

Authors:  Muhammad Zain Mushtaq; Syed Ahsan Ali; Zaibunnisa Sattar; Saad Bin Zafar Mahmood; Tazein Amber; Mehmood Riaz
Journal:  Arch Rheumatol       Date:  2021-10-18       Impact factor: 1.007

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.